After careful consideration, CME Group will be winding down most of its regulatory reporting services listed below, on or by 30th November 2020. This decision follows an evaluation of our Regulatory Reporting business portfolio following the acquisition of NEX Group in November 2018 which determined it no longer aligns with the strategic direction of CME Group.
We would to take this opportunity to thank you for your ongoing support of the NEX Regulatory Reporting (NRR) and Global Repository Services business at CME Group.
The impacted businesses are as follows:
- NEX Regulatory Reporting (NRR or aka CME Regulatory Reporting)
- NRR (Abide) Hub
- NEX Abide Trade Repository (NATR)
- NRR (Abide) ARM
- NRR (Abide) APA
- Legacy CME Global Repository Service (GRS)
- CME European Trade Repository (ETR)
- CME Australian Trade Repository (ATR)
During the coming months, CME Group is committed to working closely with all clients, partners and regulators to ensure a smooth transition and an orderly wind down of business operations while aiding clients in their transfer to new reporting and Trade Repository vendors. Please click here to access an FAQ resource covering the chronology and impact of this decision on each business operations component.
CME Regulatory Reporting File specifications – click the regime name for access to the NRR specifications;
Should you have any questions please do not hesitate to contact NRR at email@example.com or through your sales representative.
You may find the below pages from other vendors helpful;